A group of Swedish psychiatrists emphasise the importance of treating ADHD as a practical clinical tool rather than an all-encompassing explanation, advocating for more nuanced assessments and personalised support strategies.
The debate over attention deficit hyperactivity disorder does not require a choice between defending current diagnosis practices and scrapping the label altogether, a group of Swedish psychiatrists argues in a reply in Svenska Dagbladet. Their central point is that ADHD should be treated less as a grand explanation for every difficulty and more as a practical clinical tool that can help identify a specific pattern of persistent problems.
Markus Heilig, Paul Lichtenstein, Mikael Landén and Martin Ingvar say psychiatric diagnoses are always imperfect, but still useful when they help clinicians recognise recurring difficulties with attention, impulsivity, activity regulation and organisation. They argue that a diagnosis can make it easier for patients to understand themselves, reduce shame and point towards concrete adjustments in school, at work and in treatment.
At the same time, the authors warn that ADHD can be overused as an explanation for concentration problems that may be shaped by sleep, stress, anxiety, motivation or difficult life circumstances. They say the current system, with dedicated neuropsychiatric assessments and narrow ADHD pathways, can push broader questions about function, context and coexisting conditions into the background.
Their argument is reinforced by earlier research. A 2012 systematic review found that treatment for ADHD was linked to better long-term outcomes in most cases, including academic performance, antisocial behaviour and work life, although it did not fully normalise outcomes. Other reviews and clinical summaries have similarly found that treatment can reduce risks tied to substance misuse, criminal behaviour, depression and road crashes, while also improving social and occupational functioning.
The Swedish authors also cite evidence from long follow-up studies suggesting that medication can bring meaningful benefits for some patients, including better clinical and functional outcomes. But they stress that treatment must be regularly reviewed, since not everyone improves and the balance between benefit and risk can change over time. International clinical guidance also notes possible drawbacks, including misdiagnosis, side effects and misuse of medication.
Their broader conclusion is that ADHD should be normalised rather than either inflated into a catch-all explanation or dismissed as meaningless. In their view, the right response is a fuller psychiatric assessment, more attention to a patient’s circumstances and functioning, and more flexibility in schools and workplaces, so support does not always depend on a diagnosis.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
